Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
Saved in:
| Title: | Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma. |
|---|---|
| Authors: | Othman T; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Lo MM; Department of Pharmaceutical Services, University of California, San Francisco, San Francisco, CA, USA., Andreadis CB; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Damon LE; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Ferng TT; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Gaensler KML; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Lee JC; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Martin TG; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Olin RL; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Sayre PH; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Smith CC; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Logan AC; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Sep; Vol. 66 (9), pp. 1749-1752. Date of Electronic Publication: 2025 May 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2496333 |
